Title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata |
---|---|
Disease/Condition | Skin Disorders,Dermatology |
Eligibility Criteria | Click here for eligibility requirements |
Principal Investigator | Steven Cohen, MD |
Contact Name | Jose Jaller |
Contact Email | jjaller@montefiore.org |
IRB/Protocol Number | 18-02-401-01 |
Status | Active/Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Sub-Specialty | Dermatology |